ATE404693T1 - Neue kontrollpunktgene des zellzykluses und proteine, für die sie kodieren - Google Patents

Neue kontrollpunktgene des zellzykluses und proteine, für die sie kodieren

Info

Publication number
ATE404693T1
ATE404693T1 AT00965026T AT00965026T ATE404693T1 AT E404693 T1 ATE404693 T1 AT E404693T1 AT 00965026 T AT00965026 T AT 00965026T AT 00965026 T AT00965026 T AT 00965026T AT E404693 T1 ATE404693 T1 AT E404693T1
Authority
AT
Austria
Prior art keywords
proteins
cell cycle
cycle checkpoint
encoding
new cell
Prior art date
Application number
AT00965026T
Other languages
English (en)
Inventor
Paul Russell
Jorge Vialard
Michael Boddy
Paul Shanahan
Antonia Lopez-Girona
Cecile-Marie Denis
Clare H Mcgowan
Original Assignee
Scripps Research Inst
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst, Janssen Pharmaceutica Nv filed Critical Scripps Research Inst
Application granted granted Critical
Publication of ATE404693T1 publication Critical patent/ATE404693T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Error Detection And Correction (AREA)
AT00965026T 1999-09-14 2000-09-14 Neue kontrollpunktgene des zellzykluses und proteine, für die sie kodieren ATE404693T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15383699P 1999-09-14 1999-09-14

Publications (1)

Publication Number Publication Date
ATE404693T1 true ATE404693T1 (de) 2008-08-15

Family

ID=22548950

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00965026T ATE404693T1 (de) 1999-09-14 2000-09-14 Neue kontrollpunktgene des zellzykluses und proteine, für die sie kodieren

Country Status (15)

Country Link
US (3) US6440732B1 (de)
EP (1) EP1214453B1 (de)
JP (1) JP4871468B2 (de)
KR (2) KR100851511B1 (de)
AT (1) ATE404693T1 (de)
AU (1) AU784443B2 (de)
CA (1) CA2385266C (de)
DE (1) DE60039895D1 (de)
DK (1) DK1214453T3 (de)
ES (1) ES2311472T3 (de)
IL (2) IL148595A0 (de)
NO (1) NO20021255L (de)
NZ (1) NZ518236A (de)
WO (1) WO2001020038A1 (de)
ZA (1) ZA200202863B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070021361A1 (en) * 2002-12-04 2007-01-25 Shuster Samuel J Methods and materials for modulating trpm2
US7396669B2 (en) * 2004-06-30 2008-07-08 The Scripps Research Institute Mammalian endonucleases and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801154A (en) * 1993-10-18 1998-09-01 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of multidrug resistance-associated protein
US5552390A (en) * 1993-12-09 1996-09-03 The Board Of Regents Of The University Of Nebraska Phosphorothioate inhibitors of metastatic breast cancer
AU6764398A (en) * 1997-03-20 1998-10-12 Variagenics, Inc. Target genes for allele-specific drugs
US5977341A (en) * 1998-11-20 1999-11-02 Isis Pharmaceuticals Inc. Antisense modulation of inhibitor-kappa B kinase-beta expression
US7396669B2 (en) * 2004-06-30 2008-07-08 The Scripps Research Institute Mammalian endonucleases and methods of use

Also Published As

Publication number Publication date
NO20021255L (no) 2002-05-03
US7479541B2 (en) 2009-01-20
EP1214453B1 (de) 2008-08-13
ZA200202863B (en) 2003-09-23
KR100817010B1 (ko) 2008-03-27
WO2001020038A1 (en) 2001-03-22
JP2003509069A (ja) 2003-03-11
KR20070043872A (ko) 2007-04-25
US20070213256A1 (en) 2007-09-13
IL148595A0 (en) 2002-09-12
EP1214453A4 (de) 2003-02-19
CA2385266A1 (en) 2001-03-22
NO20021255D0 (no) 2002-03-13
EP1214453A1 (de) 2002-06-19
KR20020064781A (ko) 2002-08-09
NZ518236A (en) 2004-02-27
IL148595A (en) 2008-11-26
DE60039895D1 (de) 2008-09-25
US7214790B2 (en) 2007-05-08
AU784443B2 (en) 2006-04-06
CA2385266C (en) 2011-05-24
JP4871468B2 (ja) 2012-02-08
KR100851511B1 (ko) 2008-08-11
AU7581700A (en) 2001-04-17
US6440732B1 (en) 2002-08-27
ES2311472T3 (es) 2009-02-16
DK1214453T3 (da) 2008-10-13
US20070072794A1 (en) 2007-03-29

Similar Documents

Publication Publication Date Title
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
DE60033138D1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
DE69434663D1 (de) Nukleotid-sequenzen zur kontrolle der exprimierung von dns-sequenzen in einem zellulärem wirt
DE69534733D1 (de) NEUARTIGE AUF p53 ANSPRECHENDE GENE
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
HK1158529A1 (en) Promoters exhibiting endothelial cell specificity and methods of using same
ATE450603T1 (de) Polypeptide mit verzweigungsenzym-aktivität und für diese kodierende nukleinsäuren
WO2004061122A3 (en) Cell proliferation-related polypeptides and uses therefor
BR9912455A (pt) ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
TR200200693T2 (tr) Gen ifadesinin kontrolü için bitkisel düzenleyici sekanslar
ATE310085T1 (de) Cyclin-e2 proteine und dafür kodierende gene
ATE404693T1 (de) Neue kontrollpunktgene des zellzykluses und proteine, für die sie kodieren
ATE316138T1 (de) Rekombinante expression von s-layer-proteinen
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO2003062386A3 (en) Syndecans and angiogenesis
DE69828902D1 (de) Polypeptide mit 5-aminolevulinsäure synthaseaktivität und deren nukleinsäuren
CA2302828A1 (en) Sequence-determined dna fragments and corresponding polypeptides encoded thereby
DE59914061D1 (de) Das gen prv-1 und dessen verwendung
ATE547427T1 (de) Verfahren zur rekombinanten herstellung von ribonukleoproteinen
NO971359L (no) Humant galaktokinase-gen
ATE409225T1 (de) Durch wnt-1 induzierbare gene

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1214453

Country of ref document: EP